Australia, March 18 -- Prodigy Biotech Inc., owns the trademark (2399459) for 'PRODIGY BIOTECH' till Oct. 20, 2033.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutics and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product, namely, antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments]
Type of Mark: Word
Date of Acceptance: Jan. 7
Registration Advertised: March 17
For further details contact Henry Hughes IP Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2399459.
Disclaimer: Curated by HT Syndication.
